Concepedia

ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival

Wilko Weichert, Thomas Knösel, Joachim Bellach, M Dietel, Glen Kristiansen

Journal of Clinical Pathology · 2004 · 259 citations · 11 references

Open access

Abstract

ALCAM is frequently upregulated in colorectal cancer and is a new independent prognostic marker, underscoring the importance of ALCAM in tumour progression in this disease.

References

11

Cancer Statistics, 2003

Ahmedin Jemal, Thomas S. Murray, Alicia Samuels et al. · CA A Cancer Journal for Clinicians · 2003 · 3.3K citations · Full text

Epidemiology Of Cancer, Cancer Registration, Epidemiology Of Aging +16

Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.

Michael A. Bowen, Dhavalkumar D. Patel, X Li et al. · The Journal of Experimental Medicine · 1995 · 383 citations · Full text

Cell Adhesion, Immunology, Immune Regulation +19

Tumour markers of prognosis in colorectal cancer

Howard L. McLeod, Graeme I. Murray · British Journal of Cancer · 1998 · 229 citations · Full text

Tumor Biology, Medicine, Colorectal Cancer +4

Activated Leukocyte Cell Adhesion Molecule/CD166, a Marker of Tumor Progression in Primary Malignant Melanoma of the Skin

Léon C.L.T. van Kempen, Joost J. van den Oord, Goos N.P. van Muijen et al. · American Journal Of Pathology · 2000 · 208 citations

Tumor Biology, Cancer Immunosurveillance, Primary Malignant Melanoma +9

MOLECULAR GENETIC PROFILING OF GLEASON GRADE 4/5 PROSTATE CANCERS COMPARED TO BENIGN PROSTATIC HYPERPLASIA

Thomas A. Stamey, Janet A. Warrington, MITCHELL C. CALDWELL et al. · The Journal of Urology · 2001 · 186 citations